Recent Advances in DNA Vaccines against Lung Cancer: A Mini Review

Lung cancer is regarded as the major causes of patient death around the world. Although the novel tumor immunotherapy has made great progress in the past decades, such as utilizing immune checkpoint inhibitors or oncolytic viruses, the overall 5-year survival of patients with lung cancers is still l...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ting, Liu, Li, Lv, Zheng, Zhao, Kelei, Yi, Qiong, Zhang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612219/
https://www.ncbi.nlm.nih.gov/pubmed/36298450
http://dx.doi.org/10.3390/vaccines10101586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612219/
https://www.ncbi.nlm.nih.gov/pubmed/36298450
http://dx.doi.org/10.3390/vaccines10101586

Ejemplares similares